Abu Dhabi, UAE — Mubadala Investment Company (MIC) has entered into a strategic partnership with US-based fund-of-funds venture capital firm Blue Opal Capital and will be an anchor investor in their second venture capital fund.
Blue Opal Capital recently launched a Fund-of-Fund platform that focuses on identifying and investing in exceptional entrepreneurial venture capitalists, with particular emphasis on opportunities within the United States.
Blue Opal Capital invests in emerging venture capital funds and co-investment opportunities that maximize investment returns for their partners.
Faris al Mazrui, Head of Growth Investments at Mubadala, said, “We are excited to back the Blue Opal Capital team, led by Ahmed Al Mosa, Sebastien de Jong and Federico Jost. The team has a solid track record and a demonstrated ability to identify emerging managers who have matured into top-quartile VC firms.”
“We see this partnership as an opportunity to continue building on Mubadala’s commitment to the space and are confident in Blue Opal Capital’s ability to anchor the next wave of VC managers in the US,” he said.
Ahmed Al Mosa, Partner at Blue Opal Capital, stated, “This partnership with Mubadala not only underscores our dedication to driving value and innovation but also aligns perfectly with our mission and vision for the future.
Last month, Mubadala Capital, the wholly owned asset management subsidiary of Mubadala Investment Company, and Woori Venture Partners, a wholly owned subsidiary of South Korea’s leading financial group Woori Financial Group, signed an MoU to explore mutually beneficial global investment opportunities in various sectors.
Read full story here: Mubadala Capital and Woori sign partnership
Also in February, Goldman Sachs and Mubadala Investment Company signed a $1 billion separately managed account (Partnership) in which Mubadala and Goldman Sachs Alternatives will co-invest in private credit opportunities throughout the Asia Pacific region.
In the same month, Mubadala Investment Company announced that it is investing in Manipal Health Enterprises (Manipal). Temasek, a Singapore-headquartered global investment company, will continue to hold a majority stake in Manipal.